SPONSOR
Radboud University Medical Center
Total Trials
12
Recruiting
12
Phases
Phase 4, Phase 3, Phase 2
Conditions studied: Post-ERCP Acute PancreatitisDystonic Tremor SyndromeMovement DisordersParkinson DiseaseRecurrent Urinary Tract InfectionIschemic StrokeStroke in the YoungCardiovascular DiseasesCerebrovascular DisordersEmbolism and Thrombosis
Radboud University Medical Center is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Post-ERCP Acute Pancreatitis, Dystonic Tremor Syndrome, Movement Disorders, Parkinson Disease.
The trial portfolio spans Phase 4, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Radboud University Medical Center
How many clinical trials has Radboud University Medical Center sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by Radboud University Medical Center, of which 12 are actively recruiting participants. These trials cover conditions including Post-ERCP Acute Pancreatitis, Dystonic Tremor Syndrome, Movement Disorders. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Radboud University Medical Center research focus on?
Radboud University Medical Center clinical trials span Post-ERCP Acute Pancreatitis, Dystonic Tremor Syndrome, Movement Disorders, Parkinson Disease, Recurrent Urinary Tract Infection, and additional conditions. The research pipeline includes Phase 4, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Radboud University Medical Center clinical trial?
To participate in a Radboud University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Radboud University Medical Center trials with current recruitment status updated daily.
Clinical Trials by Radboud University Medical Center
NCT05267379
Recruiting
An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
Post-ERCP Acute Pancreatitis
NCT06411028 Phase 4
Recruiting
Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia
Dystonic Tremor Syndrome
NCT04848077
Recruiting
STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease
Movement Disorders
NCT05652374 Phase 4
Recruiting
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
Recurrent Urinary Tract Infection
NCT05853796
Recruiting
Observational Dutch Young Symptomatic StrokE studY - nEXT
Ischemic Stroke
NCT06057519 Phase 3
Recruiting
Pragmatic Optimized Rifampicin Trial
Tuberculosis, Pulmonary
NCT05192057 Phase 4
Recruiting
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
Nontuberculous Mycobacterial Lung Disease
NCT07293858
Recruiting
Optical Coherence Tomography: Prognostic Value and Artificial Intelligence
Coronary Arterial Disease
NCT06512493
Recruiting
South East (Zuid Oost) Netherlands Heart Registry
Coronary Artery Disease
NCT06082492
Recruiting
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
Stage III Non-small Cell Lung Cancer
NCT04523909
Recruiting
Trajectory of Neuroinflammatory Markers in Cerebrospinal Fluid Prior to and After Thoracic Aortic Surgery
Postoperative Delirium
NCT05513365 Phase 2
Recruiting
Phase II Dutasteride in Combination With CAB vs CAB in SDC
Salivary Duct Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology